News

BioPharma Dive
biopharmadive.com > news > trump-revives-pharma-tariffs-100-percent-levies > 816584

Trump revives pharma tariffs with 100% charges, but leaves loopholes

4+ hour, 59+ min ago  (516+ words) Section 232" national security levies won't apply to a wide array of drugs, meaning the overall threat to the sector should be low," according to one analyst. The Trump administration has revived tariffs on imported pharmaceuticals, applying 100% levies on drugs under…...

BioPharma Dive
biopharmadive.com > news > trump-rx-drug-prices-discount-white-house > 811576

White House’s online service for drug sales debuts with limited impact on prices

1+ mon, 3+ week ago  (308+ words) Select products from Pfizer, Eli Lilly and others will be sold at a discount, although the lower costs won't be felt by many Americans whose medications are covered by insurance. Direct-to-consumer drug sales, which bypass traditional methods of paying for…...

BioPharma Dive
biopharmadive.com > news > abbvie-drug-price-deal-trump-most-favored-nation > 809441

AbbVie pledges $100B to US production in drug pricing deal with Trump

2+ mon, 3+ week ago  (360+ words) As with the many other "most-favored-nation" deals between the White House and large pharmas, the agreement is short on details as well as its potential financial impact. AbbVie is the latest among more than a dozen of the world's largest…...

BioPharma Dive
biopharmadive.com > news > trump-most-favored-nation-drug-price-deals > 808466

Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump

3+ mon, 1+ week ago  (502+ words) Analysts see little effect on the bottom lines of biopharma companies, as they stand to stave off tariff pressure and receive other benefits from the agreements. A new round of pricing deals between the White House and pharmaceutical companies will…...

BioPharma Dive
biopharmadive.com > news > medicare-price-negotiation-wegovy-ozempic-trelegy-2027 > 806526

CMS sets 2027 Medicare prices for Wegovy, Trelegy and 13 other drugs

4+ mon, 1+ week ago  (447+ words) The second round of negotiations cuts spending an aggregate 44% over 2024 list prices as the federal government extends restraints over more medicines. Medicare will pay billions of dollars less in 2027 for 15 drugs, including major medicines for cancer, asthma and metabolic conditions,…...

BioPharma Dive
biopharmadive.com > news > astrazeneca-drug-price-novo-plant-fda-novavax-sale > 802677

AstraZeneca cuts US drug pricing deal; FDA declares Novo plant out of compliance

5+ mon, 2+ week ago  (644+ words) AstraZeneca followed the blueprint of a deal Pfizer recently cut with the White House. Elsewhere, Novo is shuttering its cell therapy division and an investor wants Novavax to sell itself. Don't miss tomorrow's biopharma industry news AstraZeneca cuts US drug…...

BioPharma Dive
biopharmadive.com > news > pfizer-trump-drug-pricing-deal-most-favored-nation > 761502

Trump, Pfizer drug pricing deal short on details, possible impact

6+ mon, 3+ day ago  (493+ words) A pact to offer "most favored nation" prices to state Medicaid programs and via direct-to-consumer channels doesn't affect those on commercial insurance or who won't pay out of pocket. The actual impact of Tuesday's agreement on the prices paid by…...